CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 255 filers reported holding CONMED CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $266,586 | -23.3% | 3,329 | +4.9% | 0.00% | -100.0% |
| Q4 2023 | $347,366 | +11.3% | 3,172 | +2.5% | 0.00% | 0.0% |
| Q3 2023 | $312,131 | -22.3% | 3,095 | +4.7% | 0.00% | 0.0% |
| Q2 2023 | $401,555 | +31.1% | 2,955 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $306,283 | +13.3% | 2,949 | -3.3% | 0.00% | 0.0% |
| Q4 2022 | $270,441 | +10.4% | 3,051 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $245,000 | -17.5% | 3,051 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $297,000 | -35.7% | 3,097 | -0.4% | 0.00% | 0.0% |
| Q1 2022 | $462,000 | +9.0% | 3,108 | +3.9% | 0.00% | 0.0% |
| Q4 2021 | $424,000 | +7.3% | 2,990 | -0.9% | 0.00% | 0.0% |
| Q3 2021 | $395,000 | -1.2% | 3,016 | +3.6% | 0.00% | 0.0% |
| Q2 2021 | $400,000 | +11.1% | 2,912 | +5.6% | 0.00% | 0.0% |
| Q1 2021 | $360,000 | +12.9% | 2,758 | -3.3% | 0.00% | 0.0% |
| Q4 2020 | $319,000 | – | 2,852 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
| HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
| Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
| J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
| Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
| OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
| MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
| 361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |